Post-approval studies (Phase 4)UnknownNCT01336192What this trial is testingMaintenance Gemcitabine in the Chinese Advanced Lung CancerWho this might be right forNon Small Cell Lung Cancer Tongji University 240
Early research (Phase 1)Study completedNCT02182232What this trial is testingA Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 33
Testing effectiveness (Phase 2)Study completedNCT00622193What this trial is testingDose Range Study of Anamorelin in Patients With Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Helsinn Therapeutics (U.S.), Inc 228
Testing effectiveness (Phase 2)Ended earlyNCT03827850What this trial is testingFGFR Inhibitor in FGFR Dysregulated CancerWho this might be right forLung CancerNSCLCPulmonary Neoplasm+2 more Lung Cancer Group Cologne 22
Testing effectiveness (Phase 2)Study completedNCT04997382What this trial is testingChemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLCWho this might be right forNon-small Cell Lung Cancer Hunan Province Tumor Hospital 112
Testing effectiveness (Phase 2)Looking for participantsNCT06712680What this trial is testingA Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver GenesWho this might be right forSolid Tumor Sichuan Huiyu Pharmaceutical Co., Ltd 115
Testing effectiveness (Phase 2)UnknownNCT03693326What this trial is testingPDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic AbnormalitiesWho this might be right forCancerLung Cancer MetastaticImmunotherapy Asan Medical Center 70
Early research (Phase 1)Study completedNCT00004225What this trial is testingGene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerWho this might be right forLung Cancer Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT06868485What this trial is testingAssess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Wayshine Biopharm, Inc. 40
Not applicableWithdrawnNCT05116618What this trial is testingDetection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearrangedWho this might be right forNon-Small Cell Lung Cancer University of Colorado, Denver
Testing effectiveness (Phase 2)UnknownNCT03424759What this trial is testingUncommon EGFR AZD9291Who this might be right forNon Small Cell Lung Cancer Samsung Medical Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT04302025What this trial is testingMultiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung Cancer Genentech, Inc. 99
Testing effectiveness (Phase 2)Study completedNCT02733250What this trial is testingPembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung CancerWho this might be right forLung Cancer Centre hospitalier de l'Université de Montréal (CHUM) 10
Testing effectiveness (Phase 2)Study completedNCT02031458What this trial is testingAtezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 667
Not applicableStudy completedNCT00898417What this trial is testingBiomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without BevacizumabWho this might be right forLung Cancer ECOG-ACRIN Cancer Research Group 90
Testing effectiveness (Phase 2)Study completedNCT00085813What this trial is testingIspinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung CancerWho this might be right forNon-Small-Cell Lung Cancer GlaxoSmithKline 70
Large-scale testing (Phase 3)Study completedNCT02366143What this trial is testingAtezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Who this might be right forCarcinoma, Non-Small-Cell Lung Hoffmann-La Roche 1,202
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04765059What this trial is testingEvaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung Cancer AstraZeneca 98
Early research (Phase 1)Study completedNCT02526017What this trial is testingStudy of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced CancersWho this might be right forAdvanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more Five Prime Therapeutics, Inc. 313